Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract.
about
An alternatively spliced variant of mRNA for the human receptor for urokinase plasminogen activatorCrystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptideThe urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodelingMembrane-anchored uPAR regulates the proliferation, marrow pool size, engraftment, and mobilization of mouse hematopoietic stem/progenitor cells.Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer.Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in miceTwo distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways.The role and regulation of urokinase-type plasminogen activator receptor gene expression in cancer invasion and metastasis.Regulation and role of urokinase plasminogen activator in vascular remodelling.A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular diseaseThe urokinase receptor: involvement in cell surface proteolysis and cancer invasion.Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice.Transgenic mice demonstrate novel promoter regions for tissue-specific expression of the urokinase receptor gene.Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumours.Isolation and characterization of multiple isoforms of the rat urokinase receptor in osteoblasts.A guide to murine fibrinolytic factor structure, function, assays, and genetic alterations.Generation and characterization of urokinase receptor-deficient mice.Serum suPAR in patients with FSGS: trash or treasure?Plasminogen activator inhibitor type 1 in cancer: therapeutic and prognostic implications.Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom alpha-neurotoxins.Spontaneous lung and lymph node metastasis in transgenic breast cancer is independent of the urokinase receptor uPAR.The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuria.Overexpression of urokinase receptor in breast cancer cells results in increased tumor invasion, growth and metastasis.Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line A549.Structural requirements for glycosyl-phosphatidylinositol-anchor attachment in the cellular receptor for urokinase plasminogen activator.Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator.Modulation of urokinase and urokinase receptor gene expression in human renal cell carcinoma.Converging signals synergistically activate the LAMC2 promoter and lead to accumulation of the laminin gamma 2 chain in human colon carcinoma cells.Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints.The urokinase plasminogen activator receptor-associated protein/endo180 is coexpressed with its interaction partners urokinase plasminogen activator receptor and matrix metalloprotease-13 during osteogenesis.Increased stromal expression of murine urokinase plasminogen activator in a human breast cancer xenograft model following treatment with the matrix metalloprotease inhibitor, batimastat.Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity.Patterns of protease production during prostate cancer progression: proteomic evidence for cascades in a transgenic model.
P2860
Q24316221-8F4679D0-1F3B-470C-A879-BEF41086CCA3Q24529128-F46E7C2A-CC07-421F-ADC6-0DE7D688A4F4Q28257803-D4F17F62-4EDB-4BF4-B4A6-55C47AF87820Q30486721-F574D216-6A01-4492-8591-BDC6A7F24239Q33872298-B8777164-141B-4D2F-A2F4-F101E1051E91Q33907027-8FF80C30-ED16-4A13-9046-6D060DFCC080Q33974535-F6D5C788-EE78-486D-89E5-4D5171BDC9D9Q34103424-0542C715-00E7-41BD-9C53-94C5C5701633Q34165118-72BBF1BF-AE89-4173-8E94-BF5148479021Q34736190-AD79FC14-9EA3-4EB7-8842-0DFE975533C2Q35132279-ECA23A0A-9027-449D-8362-5078379469CEQ35240620-77974967-169C-4600-B906-E9BF166E865FQ35747177-A2C9B082-B08A-4F46-9841-2C12AC8C4AA2Q35791732-F4B56110-56C0-4FB4-B144-64DD89290913Q36623099-387D2323-80DB-4EA8-844D-A63178E71263Q36762530-A85E0159-2D53-45E5-9BB7-0B989E7BAD20Q36777944-4B95A49C-3B70-43CB-9D70-0E04BC18984CQ37351869-F332CFCF-18CA-4279-A47B-36505E8CD99EQ38091638-5C2D0625-2032-47CA-B2CF-761977A65072Q40475372-1D538735-D1DF-4479-B063-2F5A9518FB31Q40683497-A0C59D19-ABF6-4E6B-AB8A-303B127FC84AQ40872425-77662D06-EEA0-4B26-9179-2151831297B9Q40993621-35758F37-0141-4BA5-AFCA-488C427A71C7Q41182745-9FB81BAF-41E9-4B58-8B19-8308B145EB5CQ41311259-5A88746A-52CA-490D-9C10-88224BB3EB6DQ41606805-28BEDE5B-E65E-4CBE-A196-C513679E41FBQ41629036-D12C5AF6-706F-4F8E-BD86-77827535C79FQ42064350-D0231D40-570B-487E-AEB3-EA094DBDAE17Q42181408-68D0CEC4-6516-4FF8-9537-9037CC20957FQ43053623-7B476165-AA4E-46B9-A492-81C7B6CF61A5Q43764719-B38DC891-CDC8-4246-8D14-F4A40184657AQ43811861-0F71EBF2-4596-4BB9-830E-A8D5D6E834BCQ44111674-77A61D4E-9749-41AB-9E2C-B27EFCD2BE0DQ44685331-59FAF1A5-02FB-4E24-9037-103289412347
P2860
Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Two alternatively spliced mous ...... in the gastrointestinal tract.
@en
type
label
Two alternatively spliced mous ...... in the gastrointestinal tract.
@en
prefLabel
Two alternatively spliced mous ...... in the gastrointestinal tract.
@en
P2093
P2860
P356
P1476
Two alternatively spliced mous ...... in the gastrointestinal tract.
@en
P2093
P2860
P304
P356
10.1083/JCB.115.6.1763
P407
P577
1991-12-01T00:00:00Z